Vanguard Asset Management
ROIV icon

Vanguard Asset Management’s Roivant Sciences ROIV Stock Holding History

Vanguard Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
450,327
+98,458
+28% +$2.91M 0.01% 590
2026
Q1 		$9.75M Buy
+351,869
New +$9.04M 0.01% 673

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Asset Management's ROIV Position: Q2 2026 in Review

Vanguard Asset Management increased its Roivant Sciences (ROIV) stake by 28% in Q2 2026, buying an estimated $2.91M and bringing the position to 450,327 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #590.

Vanguard Asset Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vanguard Asset Management held 450,327 shares of Roivant Sciences worth $15.9M as of Q2 2026.
  • Vanguard Asset Management bought 98,458 Roivant Sciences shares in Q2 2026, an estimated $2.91M.
  • Roivant Sciences made up 0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #590 holding.
  • Vanguard Asset Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.